The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Nanooncology: The future of cancer diagnosis and therapy
Open accessAbstract
In recent years, there has been an unprecedented expansion in the field of nanomedicine with the development of new nanoparticles for the diagnosis and treatment of cancer. Nanoparticles have unique biological properties given their small size and large surface area‐to‐volume ratio, which allows them to bind, absorb, and carry compounds such as small molecule drugs, DNA, RNA, proteins, and probes with high efficiency. Their tunable size, shape, and surface characteristics also enable them to have high stability, high carrier capacity, the ability to incorporate both hydrophilic and hydrophobic substances and compatibility with different administration routes, thereby making them highly attractive in many aspects of oncology. This review article will discuss how nanoparticles are able to function as carriers for chemotherapeutic drugs to increase their therapeutic index; how they can function as therapeutic agents in photodynamic, gene, and thermal therapy; and how nanoparticles can be used as molecular imaging agents to detect and monitor cancer progression. CA Cancer J Clin 2013;63:395‐418 . © 2013 American Cancer Society, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–210 of 210
An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer.
Yavari, N., Andersson‐Engels, S., Segersten, U., & Malmström, P. (2011) · PubMed · Cited by 51
Photodynamic therapy for prostate cancer-an emerging approach for organ-confined disease
Moore, C. M., Emberton, M., & Bown, S. G. (2011) · Lasers in Surgery and Medicine · doi:10.1002/lsm.21104 · Cited by 35
Lee, H. J., Nguyen, Y. T. C., Muthiah, M., Vu-Quang, H., Namgung, R., Kim, W. J., Yu, M., Jon, S., Lee, I. K., Jeong, Y. Y., et al. (2012) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2012.1407 · Cited by 34
Polyreaktionen ?Mechanismen, Systematik, Relevanz
Geckeler, K. E., & Stirn, J. (1993) · Die Naturwissenschaften · doi:10.1007/bf01140804 · Cited by 28
Transcatheter Arterial Embolization with Zinostatin Stimalamer for Hepatocellular Carcinoma
Okusaka, T., Okada, S., Ueno, H., Ikeda, M., Iwata, R., Furukawa, H., Takayasu, K., Moriyama, N., Sato, T. S., & Sato, K. (2002) · Oncology · doi:10.1159/000059570 · Cited by 26
Use of photodynamic therapy in malignant lesions of stomach, bile duct, pancreas, colon and rectum.
Wang, J. B., & Liu, L. X. (2007) · PubMed · Cited by 26
Montanari, M., Fabbri, F., Rondini, E., et al. (2012) · Tumori Journal · doi:10.1177/030089161209800604 · Cited by 22
FDA approves liposomal vincristine (Marqibo) for rare leukemia.
Ingram, I. (2012) · PubMed · Cited by 21
Clinical development of new formulations of cytotoxics in solid tumors
Azim, H. A., & Awada, A. H. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328351fb29 · Cited by 10
Aberrant type I and type III collagen gene expression in human breast cancerin vivo
Kauppila, S., Stenbäck, F., Risteli, J., Jukkola, A., & Risteli, L. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(1998110)186:3
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,075
Self-citationPolymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects
Begines, B., Ortiz, T., Pérez-Aranda, M., Martínez, G., Merinero, M., Argüelles-Arias, F., & Alcudia, A. (2020) · Nanomaterials · doi:10.3390/nano10071403 · Cited by 1,061
Augustine, R., Hasan, A., Primavera, R., Wilson, R. J., Thakor, A. S., & Kevadiya, B. D. (2020) · Materials Today Communications · doi:10.1016/j.mtcomm.2020.101692 · Cited by 562
Self-citationCancer Treatment through Nanoparticle-Facilitated Fenton Reaction
Ranji-Burachaloo, H., Gurr, P. A., Dunstan, D. E., & Qiao, G. G. (2018) · ACS Nano · doi:10.1021/acsnano.8b07635 · Cited by 559
Metadata
- Authors
- Thakor, A. S., & Gambhir, S. S.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2013-10
- Volume
- 63
- Issue
- 6
- Pages
- 395-418
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2080202676
- Cited by
- 588
- References
- 210
- FWCI
- 17.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.